SMO and ovarian carcinoma: In order to examine if the activated Hh pathway is essential for the proliferation of ovarian carcinoma cells, A2780, SKOV-3 and OVCAR-3 were exposed to increasing concentration of KAAD-cyclopamine, a compound able to inhibit both Hh ligand-dependent and independent pathway activation, through direct interaction with Smo.